|
Market Closed -
Australian S.E.
00:47:26 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 6.740 AUD | +5.64% |
|
+13.85% | +105.49% |
| 09:31pm | Tetratherix Receives US FDA Review Update for Bone Regeneration Device; Shares Up 5% | MT |
| 09-15 | Tetratherix Completes First Preclinical Performance Study for Eye Surgery Device | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- TTX Stock
- Consensus Tetratherix Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
